$41.930
+0.109 (+0.26%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
ELVN 相似圖表分析預測
Alphio's ELVN stock price prediction model matches the current Enliven Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $41.68 (-0.60%). The 1-week path is $40.48 (-3.45%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Enliven Therapeutics Inc 股票嗎?
Enliven Therapeutics Inc is a good buy right now due to its strong cash reserves of $895.2 million, which ensures liquidity into 2030, and a current price of $37.32 significantly below analyst price targets ranging from $70 to $82. The main risk is the negative earnings trend, with an EPS of -0.49 reported last quarter, missing expectations by $0.10.
ELVN 股價於 Thursday 收在 $41.93,此前上漲 +0.26%
Enliven Therapeutics Inc (ELVN) last closed at $41.93, gaining +0.26%. These facts feed the 1-day and 1-week ELVN price prediction above.
預測驅動因素
Enliven Therapeutics Inc(ELVN)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
相似圖表形態
近期走勢與 ELVN 最接近的股票,依相似度排序。
ELVN 季節性分析
Historically the probability of a positive October return for ELVN is 65.08%. April offers the highest probability of a positive month at 67.19%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
ELVN 十年價格預測
| 月份 | 最低價 | 平均價 | 最高價 | 潛在報酬率 |
|---|---|---|---|---|
| Oct 2026 | $16.08 | $20.22 | $24.88 | -51.77% |
| Nov 2026 | $27.09 | $27.36 | $27.66 | -34.74% |
| Dec 2026 | $17.27 | $21.26 | $25.90 | -49.29% |
2026 年,Enliven Therapeutics Inc(ELVN)預計區間為 $16.08 至 $27.66。
Enliven Therapeutics Inc 2026 年月度預測
2026 年 Oct,Enliven Therapeutics Inc 預計均價 $20.22,最低 $16.08,最高 $24.88。
2026 年 Nov,Enliven Therapeutics Inc 預計均價 $27.36,最低 $27.09,最高 $27.66。
2026 年 Dec,Enliven Therapeutics Inc 預計均價 $21.26,最低 $17.27,最高 $25.90。
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。